Trial Profile
The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2017
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic bronchitis; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 29 Jun 2017 Status changed from active, no longer recruiting to completed.
- 10 Mar 2017 New trial record